Exicure, Inc.

NasdaqCM:XCUR

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 47.19 M

Share Price

USD 7.47

Avg Daily Volume

20,585

Change (1 day)

-1.97%

Change (1 year)

358.28%

Change (YTD)

-45.36%

Exicure, Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: -45.36%

Exicure, Inc. Share Price Year-To-Date (YTD) return is -45.36% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Exicure, Inc. 52-week low Share Price is USD 31.99 on June 20, 2025, which is 328.25% above the current Share Price.
Exicure, Inc. 52-week low Share Price is USD 1.50 on June 20, 2025, which is -79.92% below the current Share Price.
Exicure, Inc. average Share Price for the last 52 weeks is USD 8.25.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NasdaqCM: XCUR

Exicure, Inc.

CEO	Mr. Andy Yoo
IPO Date	May 22, 2018
Location	United States
Headquarters	2430 North Halsted Street
Employees	7
Sector	🏥 Health Care
Industries Biotechnology 💊 Pharmaceuticals

Description

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.